Preprint Review Version 1 Preserved in Portico This version is not peer-reviewed

MLIP and its Influence on Key Oncogenic Pathways: Implications for Cancer Therapeutics

Version 1 : Received: 26 January 2024 / Approved: 29 January 2024 / Online: 29 January 2024 (05:47:34 CET)

A peer-reviewed article of this Preprint also exists.

Hamwi, M.N.; Elsayed, E.; Dabash, H.; Abuawad, A.; Aweer, N.A.; Al Zeir, F.; Pedersen, S.; Al-Mansoori, L.; Burgon, P.G. MLIP and Its Potential Influence on Key Oncogenic Pathways. Cells 2024, 13, 1109. Hamwi, M.N.; Elsayed, E.; Dabash, H.; Abuawad, A.; Aweer, N.A.; Al Zeir, F.; Pedersen, S.; Al-Mansoori, L.; Burgon, P.G. MLIP and Its Potential Influence on Key Oncogenic Pathways. Cells 2024, 13, 1109.

Abstract

Muscle-enriched A-type lamin-interacting protein (MLIP) is an emerging protein involved in cellular homeostasis and stress adaptation. Eukaryotic cells regulate various cellular processes, including metabolism, DNA repair, and cell cycle progression, to maintain cellular homeostasis. Disruptions in this homeostasis can lead to diseases such as cancer, characterized by uncontrolled cell growth and division. This review aims to explore for the first time the unique role MLIP may play in cancer development and progression, given its interactions with the PI3K/Akt/mTOR pathway, p53, and FOXO transcription factors, all critical regulators of cellular homeostasis and tumor suppression. We discuss the current understanding of MLIP's involvement in pro-survival pathways and its potential implications in cancer cells' metabolic remodeling and dysregulated homeostasis. Additionally, we examine the potential of MLIP as a novel therapeutic target for cancer treatment. This review aims to shed light on MLIP's potential impact on cancer biology and contribute to developing innovative therapeutic strategies.

Keywords

MLIP; Cancer; PI3 kinase; Akt; mTOR; Tumorigenesis

Subject

Biology and Life Sciences, Life Sciences

Comments (0)

We encourage comments and feedback from a broad range of readers. See criteria for comments and our Diversity statement.

Leave a public comment
Send a private comment to the author(s)
* All users must log in before leaving a comment
Views 0
Downloads 0
Comments 0


×
Alerts
Notify me about updates to this article or when a peer-reviewed version is published.
We use cookies on our website to ensure you get the best experience.
Read more about our cookies here.